Autoimmune Pancreatitis Clinical Trial
Official title:
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis Based on the Mechanism of Tfh Activation by Intestinal Bacteria and Endosonographic Features
The existing comprehensive diagnostic system for autoimmune pancreatitis (AIP) is complex, with multidimensional clinical information including morphological changes and a lack of specific biomarkers. Endoscopic ultrasound (EUS) can provide all the elements for morphological diagnosis of AIP, but the long learning curve and large observer differences make it difficult to popularize and promote. The cooperation units of the three regions in this project have found in the early stage that Klebsiella pneumoniae (KP) induced follicular helper T cells (Tfh) activation is an important mechanism of AIP, but the identification of pathogenic components of the strain and clinical validation need to be explored. We have established a national multicenter AIP queue in the early stage and extracted EUS audio-visual features to establish a scoring model, but intelligent assistance is still needed to improve efficiency. Therefore, we plan to integrate gut microbiota, Tfh activation markers, and EUS imaging features to establish an AI assisted multimodal diagnostic system for AIP. This study will collaborate across multiple centers to identify and validate the components that induce Tfh activation in KP bacterial cells, to extract EUS pancreatic ultrasound features and optimize artificial intelligence assisted diagnostic algorithms, and to establish and validate an artificial intelligence assisted multimodal diagnostic system based on clinical information, biomarkers, and EUS. The aim of this study is to provide new diagnosis and treatment evaluation methods for AIP with high accuracy, convenience, and easy promotion for clinical practice.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03753815 -
Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis
|
N/A | |
| Recruiting |
NCT02797665 -
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
|
N/A | |
| Recruiting |
NCT04834505 -
To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
|
||
| Recruiting |
NCT04397731 -
Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
|
||
| Not yet recruiting |
NCT06358001 -
EchoTip AcuCore Post-Market Clinical Study
|
||
| Completed |
NCT05476978 -
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
|
||
| Recruiting |
NCT01774513 -
EUS-guided Procore-biopsy in Diagnosing Autoimmune Pancreatitis
|
N/A | |
| Completed |
NCT03241797 -
Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis
|
N/A | |
| Completed |
NCT05171517 -
Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
|
||
| Withdrawn |
NCT01845467 -
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
|
||
| Completed |
NCT05565066 -
A Real-world Comparison of FNB and FNA in IHC-required Lesions.
|
||
| Withdrawn |
NCT02766842 -
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
|
Phase 2 | |
| Completed |
NCT02705638 -
Treatment of IgG4-Related Disease With Revlimid and Rituximab
|
Phase 1 | |
| Completed |
NCT01584388 -
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT00588367 -
CT Pancreas Perfusion
|
N/A |